BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11165712)

  • 1. Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation.
    Sarwal MM; Jani A; Chang S; Huie P; Wang Z; Salvatierra O; Clayberger C; Sibley R; Krensky AM; Pavlakis M
    Hum Immunol; 2001 Jan; 62(1):21-31. PubMed ID: 11165712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of cytotoxic effector molecules: different interpretations for steroid-based and steroid-free immunosuppression.
    Satterwhite T; Chua MS; Hsieh SC; Chang S; Scandling J; Salvatierra O; Sarwal MM
    Pediatr Transplant; 2003 Feb; 7(1):53-8. PubMed ID: 12581329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perforin, Granzyme B, and fas ligand for molecular diagnosis of acute renal-allograft rejection: analyses on serial biopsies suggest methodological issues.
    Graziotto R; Del Prete D; Rigotti P; Anglani F; Baldan N; Furian L; Valente M; Antonello A; Marchini F; D'Angelo A; Gambaro G
    Transplantation; 2006 Apr; 81(8):1125-32. PubMed ID: 16641597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heightened peripheral blood lymphocyte CD69 expression is neither sensitive nor specific as a noninvasive diagnostic test for renal allograft rejection.
    Karpinski M; Rush D; Jeffery J; Pochinco D; Milley D; Nickerson P
    J Am Soc Nephrol; 2003 Jan; 14(1):226-33. PubMed ID: 12506155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of acute renal allograft rejection by analyzing whole blood mRNA expression of lymphocyte marker molecules.
    Alakulppi NS; Kyllönen LE; Partanen J; Salmela KT; Laine JT
    Transplantation; 2007 Mar; 83(6):791-8. PubMed ID: 17414714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly decreases the expression of perforin, granzyme A and granulysin in human NK-92CI cell line.
    Li Q; Nakadai A; Ishizaki M; Morimoto K; Ueda A; Krensky AM; Kawada T
    Toxicology; 2005 Sep; 213(1-2):107-16. PubMed ID: 16002202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine and cytotoxic molecule gene expression determined in peripheral blood mononuclear cells in the diagnosis of acute renal rejection.
    Dugré FJ; Gaudreau S; Belles-Isles M; Houde I; Roy R
    Transplantation; 2000 Oct; 70(7):1074-80. PubMed ID: 11045645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional profiles in urine during acute rejection, bacteriuria, CMV infection and stable graft function after renal transplantation.
    Øzbay A; Tørring C; Olsen R; Carstens J
    Scand J Immunol; 2009 Apr; 69(4):357-65. PubMed ID: 19284501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of whole blood cyclosporine measurements in renal transplantation using triple therapy.
    Nankivell BJ; Hibbins M; Chapman JR
    Transplantation; 1994 Nov; 58(9):989-96. PubMed ID: 7974738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialyl Lewis(x) (CD15s) monitoring as a means to select antirejection therapy in patients with rejection after renal transplantation: CD15s monitoring for treatment and diagnosis in patients with acute rejection after renal transplantation.
    Ishida H; Koyama I; Sawada T; Murakami T; Tojimbara T; Nakajima I; Tanabe K; Yamaguchi Y; Fuchinoue S; Toma H; Agishi T
    Transplantation; 2000 May; 69(10):2208-11. PubMed ID: 10852628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential monitoring of TIM-3 gene expression in peripheral blood for diagnostic and prognostic evaluation of acute rejection in renal graft recipients.
    Luo Y; Shi B; Qian Y; Bai H; Chang J
    Transplant Proc; 2011 Dec; 43(10):3669-74. PubMed ID: 22172823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
    Carstens J; Ozbay A; Tørring C; Hansen HE
    Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings.
    Gotti E; Perico N; Perna A; Gaspari F; Cattaneo D; Caruso R; Ferrari S; Stucchi N; Marchetti G; Abbate M; Remuzzi G
    J Am Soc Nephrol; 2003 Mar; 14(3):755-66. PubMed ID: 12595513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.
    Posselt AM; Vincenti F; Bedolli M; Lantz M; Roberts JP; Hirose R
    Transplantation; 2003 Jul; 76(1):190-5. PubMed ID: 12865808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection.
    Shoker A; George D; Yang H; Baltzan M
    Transplantation; 2000 Aug; 70(3):497-505. PubMed ID: 10949194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection.
    Kotsch K; Mashreghi MF; Bold G; Tretow P; Beyer J; Matz M; Hoerstrup J; Pratschke J; Ding R; Suthanthiran M; Volk HD; Reinke P
    Transplantation; 2004 Jun; 77(12):1866-75. PubMed ID: 15223905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of fine-needle aspiration biopsies by flow cytometry in kidney transplant patients.
    Oliveira JG; Ramos JP; Xavier P; Magalhães MC; Mendes AA; Guerra LE
    Transplantation; 1997 Jul; 64(1):97-102. PubMed ID: 9233708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diagnosis of renal-allograft rejection: correlation with histopathologic evaluation and antirejection-therapy resistance.
    Desvaux D; Schwarzinger M; Pastural M; Baron C; Abtahi M; Berrehar F; Lim A; Lang P; le Gouvello S
    Transplantation; 2004 Sep; 78(5):647-53. PubMed ID: 15371663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal induced IL-2 mRNA monitoring in renal transplant patients immunosuppressed with cyclosporine and in unmodified canine renal transplant rejection.
    Zucker C; Zucker K; Asthana D; Carreno M; Viciana AL; Ruiz P; Esquenazi V; Nery J; Burke G; Miller J
    Hum Immunol; 1996 Jan; 45(1):1-12. PubMed ID: 8655354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.